K Charles Janac Sells 5,520 Shares of Arteris, Inc. (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) CEO K Charles Janac sold 5,520 shares of Arteris stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $7.18, for a total value of $39,633.60. Following the sale, the chief executive officer now directly owns 287,247 shares in the company, valued at $2,062,433.46. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

K Charles Janac also recently made the following trade(s):

  • On Thursday, September 5th, K Charles Janac sold 1,955 shares of Arteris stock. The shares were sold at an average price of $7.26, for a total transaction of $14,193.30.
  • On Tuesday, September 3rd, K Charles Janac sold 1,348 shares of Arteris stock. The stock was sold at an average price of $7.87, for a total value of $10,608.76.

Arteris Price Performance

AIP stock opened at $7.10 on Friday. The business’s 50 day moving average price is $7.52 and its two-hundred day moving average price is $7.64. Arteris, Inc. has a fifty-two week low of $4.20 and a fifty-two week high of $9.54. The company has a market capitalization of $273.20 million, a price-to-earnings ratio of -6.89 and a beta of 1.11. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.14 and a current ratio of 1.14.

Arteris (NASDAQ:AIPGet Free Report) last issued its quarterly earnings results on Thursday, August 1st. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.07). Arteris had a negative return on equity of 274.66% and a negative net margin of 68.37%. The business had revenue of $14.58 million during the quarter, compared to analysts’ expectations of $13.68 million. During the same quarter in the previous year, the company posted ($0.25) EPS. As a group, analysts forecast that Arteris, Inc. will post -0.9 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

AIP has been the subject of several recent analyst reports. Westpark Capital reaffirmed a “buy” rating and issued a $11.00 target price on shares of Arteris in a research note on Wednesday, July 31st. Rosenblatt Securities reaffirmed a “buy” rating and issued a $15.00 price target on shares of Arteris in a research note on Monday, August 5th.

Get Our Latest Research Report on AIP

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. The Manufacturers Life Insurance Company purchased a new position in Arteris during the second quarter valued at approximately $86,000. Algert Global LLC purchased a new position in shares of Arteris during the 2nd quarter worth approximately $115,000. Rhumbline Advisers grew its stake in shares of Arteris by 2,182.8% in the second quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock worth $239,000 after acquiring an additional 30,428 shares in the last quarter. CloudAlpha Capital Management Limited Hong Kong purchased a new stake in Arteris during the 2nd quarter worth about $554,000. Finally, Bank of New York Mellon Corp acquired a new stake in shares of Arteris in the 2nd quarter valued at about $580,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Articles

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.